Stock data
Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN) reported revenue of US$0.00M and net income of -US$69.79M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$79.47M | -US$69.79M | — |
| 2024 | US$0.00M | — | -US$62.38M | -US$49.59M | — |
| 2023 | — | — | -US$78.19M | -US$66.86M | — |
| 2022 | — | — | -US$67.59M | -US$63.31M | — |
| 2021 | — | — | -US$35.83M | -US$35.53M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$20.16M | — |
| 2026-03-31 | US$0.00M | -US$17.64M | — |
| 2025-12-31 | — | -US$16.00M | — |
| 2025-09-30 | — | -US$17.00M | — |
| 2025-06-30 | — | -US$19.08M | — |
| 2025-03-31 | US$0.00M | -US$17.71M | — |
| 2024-12-31 | — | -US$13.65M | — |
| 2024-09-30 | — | -US$13.04M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.